MXI1 and cancer: Taken together, the relative infrequency with which bi-allelic loss/inactivation of MXD2 occurs in human cancers suggests that haplo-insufficiency, an increasingly recognized phenomenon in a number of cancers [240,241], may be more responsible for contributing to tumorigenesis.